Modeling of 82 brand drugs with ≥$100 million Medicaid spend found net prices exceeded at least one international reference ...

Establishing mobile health clinics in rural settings requires collaboration across health systems by aligning missions, building infrastructure to support research, and demonstrating proof of concept.

A rebate-driven formulary model allegedly incentivized higher insulin list prices, affecting three PBMs controlling roughly ...

Terms & Conditions Terms & Conditions This Statement was last revised [01/16/2026] TERMS AND CONDITIONS OF USE PLEASE READ THE FOLLOWING TERMS AND CONDITIONS OF USE (THE “TERMS”) CAREFULLY BEFORE ...

Analyses spanning 35,245 patients across 13 scenarios found comparable initiation of any systemic therapy in Medicare ...

Deepak Bhatt, MD, MPH, MBA, discusses how new evidence, prevention definitions, and imaging advances are reshaping how PCSK9 ...

Evidence-Based Oncology ™ is a forum for the dissemination of clinical, pharmacoeconomic, and regulatory information to payers, health care policy experts, and providers associated with cancer care.

Our family of journals—The American Journal of Managed Care®, Population Health, Equity & Outcomes, and Evidence-Based Oncology™—is seeking to publish timely research and commentary. Find the right ...

Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

A 12-week prospective cohort enrolled 73 patients with guideline-based asthma or COPD and no speech-affecting comorbidities, ...

Epcoritamab shows high rates of first-line response and MRD negativity in older patients with chemo-ineligible DLBCL, whether used alone or with R-mini-CHOP. Current sickle cell disease (SCD) trial ...